2023-01-18 Quality Measures Full Member Meeting

Date: January 18th, 2023

Time: 3:30pm ET

Attendees (13) 

Action items

• Anthony DiDonato will send slides used for today's meeting - include updates on workflow actors (quality measures partners) and other edits recorded in the comment section of slides
• Anthony DiDonato will update spreadsheet tracking workflow actors - begin to track working group members responsible for outreach
  • prioritize orgs based on CodeX members, who we've talked with previously, no contact yet, etc.
• Anthony DiDonato  → send Use Case Development Guidelines link as a separate action item for everyone to review/provide feedback
• Doug Williams CentanniPark will provide initial workflow actor for (2) Patient Encounters (xcures - https://www.linkedin.com/in/mikanewton/)

Planned Agenda Topics

Agenda Items

1. Highlight the differences between our current Terminology call v. Full Member call
   1. Terminology: discuss clinical aspects of each measure spec; model concepts in FHIR
   2. Full Member: strategy focused; project scoping; staffing; etc.
2. Review newest draft of workflow diagram
3. Based on workflow actors, discuss engagement/outreach approach for 2023
   1. Ex) establishing who on the team will take point connecting with key organizations
   2. NCQA: CodeX met with Federation of American Hospitals (FAH) last week – Tilithia McBride, VP of Quality at FAH, heard updates regarding CodeX QM use case
      1. She recommended we connect with Fred Camacho, Head of Product Development
      2. Mary Barton – do you know Fred and would others like to join a call with his team, if we get one scheduled?
      3. Other CodeX contacts: Brad Ryan (CPO); Ben Hamlin (senior staff working on quality measures); and Keri Christensen (Director of Implementation Strategy).
4. Highlight our strategy for engaging CMS on Enhancing Oncology Model and ONC on USCDI+ 
   1. Current ideas: submit new concepts to USCDI+ and wait for EOM to publicly release measures
   2. Define key next steps
5. Review use case development guideline checklist

Discussion Notes

1. Highlight the differences between our current Terminology call v. Full Member call

1. 1. Terminology: discuss clinical aspects of each measure spec; model concepts in FHIR - every two weeks
      1. Focus on the initial models, and detailed clinical aspects of each of the elements in the model
   2. Full Member: strategy focused; project scoping; staffing; etc. - monthly

2. Review newest draft of workflow diagram - in the PPT - based on (very positive) feedback

a. Title Quality for Measures Workflow Diagram - will send after - dotted line is current state – shaded grey rectangle is current project scope

Note: USON – also does measure development (iKnowMed → sends data to McKesson (Ontada) → sends data to US Oncology)

3.  Based on workflow actors, will begin to determine engagement/outreach priorities and outreach for 2023

1. 1. Next will need to establish who on the team will take point connecting with key organizations - build a spreadsheet to track
   2. NCQA: CodeX met with Federation of American Hospitals (FAH) last week – Tilithia McBride, VP of Quality at FAH, heard updates regarding CodeX QM use case
      1. 1. She recommended we connect with Fred Camacho, Head of Product Development
         2. Mary Barton – do you know Fred and would others like to join a call with his team, if we get one scheduled?
         3. Other CodeX contacts: Brad Ryan (CPO); Ben Hamlin (senior staff working on quality measures); and Keri Christensen (Director of Implementation Strategy).

4. Discussed our strategy for engaging CMS on Enhancing Oncology Model and ONC on USCDI+ 

1. 1. Current ideas: submit new concepts to USCDI+ and wait for EOM to publicly release measures
   2. Define key next steps

5. Discussed use case development guideline checklist - will update for next Quality Measures for Cancer full member call